Technical Analysis for TGTX - TG Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 12.2 -3.56% -0.45
TGTX closed down 3.56 percent on Friday, February 16, 2018, on 77 percent of normal volume.
10 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical TGTX trend table...

Date Alert Name Type % Chg
Feb 16 Bearish Engulfing Bearish 0.00%
Feb 16 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Feb 16 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Feb 16 Outside Day Range Expansion 0.00%
Feb 16 Wide Bands Range Expansion 0.00%
Feb 15 1,2,3 Pullback Bullish Bullish Swing Setup -3.56%
Feb 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.56%
Feb 15 Wide Bands Range Expansion -3.56%
Feb 14 180 Bullish Setup Bullish Swing Setup -2.01%
Feb 14 Outside Day Range Expansion -2.01%

Older signals for TGTX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing two advanced therapies targeting hematological malignancies. The TGTX-1101 (ublituximab) is a novel, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes, which is in clinical development for patients with relapsed and refractory non-Hodgkin's lymphoma. The TGR-1202 is an orally available PI3K delta inhibitor believed to be important in the proliferation and survival of B-lymphocytes. TG Therapeutics, Inc. is headquartered in New York, New York.
Is TGTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.35
52 Week Low 4.85
Average Volume 1,533,823
200-Day Moving Average 10.4653
50-Day Moving Average 9.9345
20-Day Moving Average 11.715
10-Day Moving Average 12.175
Average True Range 0.8222
ADX 46.44
+DI 29.69
-DI 12.5
Chandelier Exit (Long, 3 ATRs ) 10.7834
Chandelier Exit (Short, 3 ATRs ) 11.6666
Upper Bollinger Band 13.2388
Lower Bollinger Band 10.1912
Percent B (%b) 0.66
BandWidth 26.014511
MACD Line 0.6806
MACD Signal Line 0.7268
MACD Histogram -0.0462
Fundamentals Value
Market Cap 760.19 Million
Num Shares 62.3 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -6.26
Price-to-Sales 3189.49
Price-to-Book 6.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.54
Resistance 3 (R3) 13.64 13.30 13.32
Resistance 2 (R2) 13.30 12.95 13.25 13.24
Resistance 1 (R1) 12.75 12.74 12.58 12.65 13.17
Pivot Point 12.40 12.40 12.32 12.35 12.40
Support 1 (S1) 11.85 12.06 11.68 11.75 11.23
Support 2 (S2) 11.51 11.85 11.46 11.16
Support 3 (S3) 10.96 11.51 11.08
Support 4 (S4) 10.86